Reduced-Toxicity Conditioning Treatments: What Clinicians Need to Know Now

This on-demand, three-part webinar series examines reduced-toxicity conditioning approaches for patients with AML and MDS undergoing hematopoietic stem cell transplantation. Designed for physicians, advanced practice providers, pharmacists, and nurses involved in HSCT patient care, the series offers practical insights applicable to both academic and community practice settings.